查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014834

術中影像市場：依影像方式、組件、應用和最終用戶分類－2026-2032年全球市場預測

Intraoperative Imaging Market by Modality, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年術中影像市場價值為 44.1 億美元，預計到 2026 年將成長至 47.1 億美元，複合年成長率為 7.42%，到 2032 年將達到 72.8 億美元。

主要市場統計數據
基準年 2025 44.1億美元
預計年份：2026年 47.1億美元
預測年份 2032 72.8億美元
複合年成長率 (%) 7.42%

在現代外科醫學中策略性地引入術中影像技術，可以從臨床需求、技術因素和組織優先事項的角度說明。

術中影像技術處於技術創新與臨床需求的交匯點，從根本上改變了外科醫師觀察解剖結構、確認切緣以及降低手術風險的方式。影像解析度、即時重建和多模態融合技術的進步，正將以往僅限於放射科的功能引入手術室，從而實現更精準、更數據驅動的手術流程。同時，醫療服務模式的變革，例如門診手術中心的興起、縮短手術時間的壓力以及對經濟高效的手術全期手術期工作流程的需求，都在加速利用影像技術改進和最佳化手術流程。

變革性的技術和營運變革相結合，正在創建一個以軟體為中心的整合式術中成像生態系統，從而最佳化臨床結果和工作流程。

在術中影像領域，一場變革正在發生，它正在重新定義手術團隊規劃、實施和檢驗手術的方式。其中一個關鍵變化是多種影像模式的融合。這使得混合平台成為可能，從而可以在手術室中同時或依次使用電腦斷層掃描（CT）、透視、磁振造影（MRI）和高解析度超音波。這種融合支援多平面可視化，並實現即時決策，從而縮短手術時間，降低再次手術的可能性。除了硬體整合之外，軟體主導的創新也正在推動高級視覺化、影像配準和人工智慧影像診斷的發展，這些技術共同建構了以準確性和可重複性為優先的全新臨床工作流程。

2025 年醫療影像設備零件進口關稅措施將如何鼓勵外科手術服務提供者整體採用在地化生產、實現供應鏈多元化並實施策略採購系統？

2025年實施的針對醫療影像組件及相關子系統進口的關稅措施，對整個術中影像價值鏈產生了一系列營運和策略影響。關鍵子組件和影像主機關稅的提高，給採購預算帶來了壓力，促使醫療系統和醫療設備製造商重新審視其供應商合約和總體擁有成本（TCO）估算。為此，一些製造商加快了在地化生產，實現了供應商多元化，並重新談判了組件採購條款，以降低進口關稅和前置作業時間波動帶來的風險。

基於詳細細分的洞察，將模態選擇、組件生命週期、臨床應用和醫療保健環境聯繫起來，從而製定術中成像的產品和服務策略。

細分分析揭示了不同臨床環境和採購管道中技術和服務應用方式的關鍵差異。就檢查方式而言，其範圍涵蓋電腦斷層掃描 (CT)、軟式和硬式內視鏡、透視、磁振造影(MRI) 和超音波。每種檢查方式都有其獨特的基礎設施要求、人員配備以及消毒流程，這些都會影響採購決策和手術室 (OR) 設計。雖然軟式內視鏡平台因其操作便利性和手術效率，在門診和微創手術中通常更受歡迎，但硬式內視鏡在結構剛性和光學性能至關重要的專業領域仍然佔據核心地位。

區域部署模式和供應鏈趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的市場進入策略和臨床檢驗途徑。

區域趨勢對術中影像領域的技術採納、採購偏好和監管參與度均有顯著影響。在美洲，對整合醫療體系和價值醫療的高度重視推動了對能夠展現手術效率和可衡量臨床效益的系統進行投資。該地區的公立和私立採購者通常尋求強大的服務網路和全面的培訓項目，以支持廣泛的臨床應用。相較之下，歐洲、中東和非洲（EMEA）地區的政策環境複雜多樣，法律規範和報銷模式差異顯著，因此供應商需要採用針對特定區域的臨床檢驗策略和靈活的商業條款，以獲得不同醫療市場的支持。

產品模組化、軟體平台和卓越的服務正在成為決定外科影像環境長期應用的關鍵競爭優勢。

術中成像領域的競爭動態是由硬體創新、軟體生態系統和服務卓越性三者相互作用所塑造的。領先的設備供應商正日益透過模組化設計實現差異化，這種設計支援現場升級和跨模式整合，從而在保持現有部署價值的同時，創造機會向上提升銷售更高級的成像功能。軟體供應商則透過與硬體製造商和醫療系統建立合作關係，並將分析、抗蝕劑準和影像整合功能直接整合到臨床工作流程中，將其價值提案從以設備為中心的銷售模式轉向以平台為中心的經常性收入模式。

為技術開發商和醫療保健系統提供切實可行的策略建議，以協調產品藍圖、服務模式和採購方法，從而永續地採用術中成像技術。

產業領導者應優先考慮平衡的策略，將技術發展與實際應用和支援系統結合。首先，應加快軟體平台的投資，以實現互通性、雲端分析和模組化升級，從而確保硬體投資的價值在多個臨床週期中得以維持。建立清晰的API策略並採用基於標準的互通性，將有助於與電子健康記錄和手術導引系統整合，從而減輕臨床團隊的負擔。其次，應擴展區域製造和分銷系統，以降低貿易政策風險並縮短前置作業時間。這將提高抵禦關稅衝擊的能力，並增強售後服務能力。

採用嚴謹的混合方法研究途徑檢驗術中影像的見解，整合了臨床醫師訪談、供應鏈圖譜、監管審查和證據檢驗驗證。

本執行摘要的調查方法結合了定性一手研究和結構化二手調查，以確保研究結果既能反映醫療專業人員的經驗，又能反映行業背景資訊。一手研究包括對外科醫生、生物醫學工程負責人、採購負責人和臨床營運經理的深入訪談，以獲取他們對技術性能、培訓需求和採購重點的第一手觀點。此外，還舉辦了專家圓桌會議，探討與混合手術室設計、設備選擇和上市後支援策略相關的實際挑戰。

本文概述了整合技術、循證應用和強力的商業化策略如何決定術中成像技術引入的成功。

術中影像技術正從一系列分散的工具發展成為一個統一的、臨床整合的系統，對提高手術精度和改善患者預後有顯著影響。多模態硬體、先進軟體和增強型服務模式的融合，為醫院和門診中心重塑手術流程、提升醫療價值創造了機會。同時，貿易政策的變化、區域監管差異以及醫保報銷重點的調整等外在因素，也正在重塑籌資策略和供應商選擇標準。能夠將技術創新與永續的服務基礎設施和可靠的臨床證據相結合的相關人員，最有可能從術中成像技術的投資中獲得最大收益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 術中影像市場：依影像方式分類

  • 電腦斷層掃描
  • 內視鏡
    • 靈活的
    • 硬度
  • 透視
  • 磁振造影
  • 超音波

第9章 術中影像市場：依組件分類

  • 裝置
  • 服務
    • 維護
    • 訓練
  • 軟體

第10章 術中影像市場：依應用領域分類

  • 心血管系統
  • 一般外科
  • 神經外科
  • 整形外科
  • 泌尿系統

第11章 術中影像市場：依最終使用者分類

  • 門診手術中心
  • 醫院

第12章 術中影像市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 術中影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 術中影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國術中影像市場

第16章：中國術中影像市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • GE Healthcare Holdings, Inc.
  • Hologic, Inc.
  • Karl Storz SE & Co. KG
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Medical International Limited
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Ziehm Imaging GmbH
Product Code: MRR-43127F7279EE

The Intraoperative Imaging Market was valued at USD 4.41 billion in 2025 and is projected to grow to USD 4.71 billion in 2026, with a CAGR of 7.42%, reaching USD 7.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.41 billion
Estimated Year [2026] USD 4.71 billion
Forecast Year [2032] USD 7.28 billion
CAGR (%) 7.42%

A strategic introduction that contextualizes clinical imperatives, technological enablers, and organizational priorities driving intraoperative imaging adoption in modern surgical care

Intraoperative imaging sits at the intersection of technology innovation and clinical demand, fundamentally altering how surgeons visualize anatomy, confirm resection margins, and reduce procedural risk. Advances in image resolution, real-time reconstruction, and modality fusion have migrated capabilities previously confined to radiology suites into the operating room, enabling more precise, data-driven interventions. Concurrent shifts in care delivery-such as the rise of ambulatory surgical centers, pressure to shorten procedure times, and the need for cost-effective perioperative workflows-are accelerating adoption and redesign of imaging-enabled surgical pathways.

Clinicians and hospital leaders are now demanding systems that integrate seamlessly with electronic health records, offer robust interoperability, and provide validated clinical workflows that demonstrably improve outcomes. At the same time, software-driven capabilities such as artificial intelligence for image enhancement and automated measurement are transitioning from pilot projects to components of commercial product offerings. As a result, product development priorities emphasize modular hardware platforms, scalable software ecosystems, and service models that support training, maintenance, and iterative software updates. This introduction frames the subsequent analysis by highlighting clinical imperatives, technology enablers, and organizational drivers that collectively shape procurement decisions and long-term strategic planning for intraoperative imaging investments.

Transformative technological and operational shifts are converging to create integrated, software-centric intraoperative imaging ecosystems that optimize clinical outcomes and workflows

The intraoperative imaging landscape is undergoing transformative shifts that redefine how surgical teams plan, execute, and verify procedures. A primary shift is the convergence of modalities into hybrid platforms that allow simultaneous or sequential use of computed tomography, fluoroscopy, magnetic resonance imaging, and high-resolution ultrasound within the operative setting. This convergence supports multi-planar visualization and enables real-time decision-making that can shorten procedures and reduce the likelihood of revision surgeries. Parallel to hardware convergence, software-led innovation is enabling advanced visualization, registration, and AI-assisted interpretation, which together are unlocking new clinical workflows centered on precision and reproducibility.

Another consequential shift concerns the operating environment itself. Hybrid operating rooms and enhanced ambulatory surgical settings are becoming standardized, prompting equipment manufacturers and health systems to rethink footprints, sterility workflows, and training programs. Additionally, value-based reimbursement and performance metrics are encouraging stakeholders to prioritize solutions that demonstrate measurable impacts on patient throughput, safety, and procedural efficacy. Supply chain resilience and regulatory harmonization are emerging as strategic considerations that influence vendor selection and partnership models. These changes collectively indicate a market moving from siloed imaging tools toward integrated, software-centric ecosystems designed for consistent clinical utility across a broad range of specialties.

How 2025 tariff actions on imported imaging components are prompting localized production, diversified supply chains, and strategic procurement adaptations across surgical providers

The tariff measures enacted in 2025 affecting imports of medical imaging components and associated subsystems have introduced a series of operational and strategic implications across the intraoperative imaging value chain. Increased duties on key subassemblies and imaging consoles have placed pressure on procurement budgets, prompting health systems and device manufacturers to reassess supplier contracts and total cost of ownership assumptions. In response, some manufacturers accelerated localization efforts, diversified supplier bases, and renegotiated component sourcing to mitigate exposure to import tariffs and potential lead-time volatility.

Operationally, supply chain managers prioritized inventory buffering for critical spares and consumables, while service organizations adapted maintenance schedules and spare-parts strategies to address longer replenishment cycles. For clinical teams, tariff-driven device cost inflation highlighted the importance of demonstrating device utility through comparative effectiveness data and procedural efficiency gains. Regulatory and procurement functions worked more closely to evaluate lifecycle costs, considering not only acquisition price but also service, training, and software update commitments. Collectively, these dynamics favored vendors with robust regional manufacturing footprints, established aftermarket support, and flexible commercial arrangements, while catalyzing strategic partnerships aimed at preserving access to advanced imaging capabilities despite shifting trade barriers.

Deep segmentation-driven insights connecting modality choices, component lifecycles, clinical applications, and care settings to inform product and service strategies for intraoperative imaging

Segmentation analysis reveals important nuance in how technologies and services are adopted across clinical contexts and procurement pathways. When considering modality, the field spans computed tomography, endoscopy with both flexible and rigid variants, fluoroscopy, magnetic resonance imaging, and ultrasound; each modality brings distinct infrastructure requirements, staffing implications, and sterilization workflows that inform purchasing decisions and OR design. Endoscopy's flexible platforms are often prioritized for ambulatory and minimally invasive procedures due to their maneuverability and procedural throughput advantages, whereas rigid endoscopes remain central to specialties requiring structural rigidity and optics performance.

Examining component-level segmentation highlights divergent business models: equipment investments coexist with recurring service needs and software lifecycles. Equipment purchases carry capital planning implications, while services-divided into maintenance and training-represent ongoing operational commitments that influence total lifecycle value. Software is increasingly the differentiator, providing interoperability, image registration, and analytics capabilities that extend the clinical utility of hardware. Application segmentation further clarifies clinical demand patterns; cardiovascular procedures, general surgery, neurosurgery, orthopedic interventions, and urology each place unique demands on image-guidance precision, intraoperative navigation, and modality selection. Finally, the end-user segmentation captures differences between ambulatory surgical centers and hospitals: ambulatory settings prioritize compact, cost-efficient systems that support high throughput, whereas hospitals typically require multi-modality platforms and advanced support services to meet complex case mixes and regulatory requirements. These layered segmentation perspectives help stakeholders tailor product design, service offerings, and commercial strategies to specific clinical and operational use cases.

Regional adoption patterns and supply chain dynamics shaping differentiated go-to-market strategies and clinical validation pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly shape technology adoption, procurement preferences, and regulatory interactions across the intraoperative imaging landscape. In the Americas, health system consolidation and a strong emphasis on value-based care are driving investments in systems that demonstrate procedural efficiency and measurable clinical benefits. Private and public purchasers in this region often seek robust service networks and comprehensive training programs to support widespread clinical deployment. In contrast, Europe, Middle East & Africa presents a diverse policy environment where regulatory frameworks and reimbursement models vary widely, prompting vendors to adopt region-specific clinical validation strategies and flexible commercial terms to gain traction across distinct healthcare markets.

Asia-Pacific exhibits rapid uptake of innovative modalities in select markets, supported by capacity expansion, government-led investment in tertiary care centers, and growing domestic manufacturing capabilities. Across regions, supply chain considerations and local regulatory approvals influence time-to-deployment and total lifecycle support commitments. These geographic distinctions underscore the importance of localized go-to-market strategies, tailored clinical evidence generation, and investments in regional service infrastructure to support adoption and long-term utilization of intraoperative imaging technologies.

How product modularity, software platforms, and service excellence are emerging as decisive competitive levers that determine long-term adoption in surgical imaging environments

Competitive dynamics within intraoperative imaging are informed by the interplay of hardware innovation, software ecosystems, and service excellence. Leading equipment providers are increasingly seeking differentiation through modular designs that enable field upgrades and cross-modality integration, thereby protecting installed-base value while creating upsell opportunities for advanced imaging features. Software vendors are pursuing partnerships with hardware manufacturers and healthcare systems to embed analytics, registration, and image-fusion capabilities directly into clinical workflows, shifting the value proposition from device-centric sales to platform-centered, recurring-revenue models.

Service and training excellence are proving to be competitive advantages; companies that offer comprehensive clinical education, responsive maintenance, and outcome-support services tend to achieve deeper penetration in complex hospital environments. Collaboration between OEMs, software developers, and clinical centers accelerates evidence generation, enabling faster adoption of novel intraoperative workflows. Additionally, strategic partnerships-spanning joint development agreements, OEM-supplier consolidation, and targeted acquisitions-are common tactics to secure technological capabilities, regional market access, and aftermarket revenues. Agencies and regulatory bodies remain important gatekeepers for product introductions, increasing the emphasis on clinical validation and post-market surveillance programs. Together, these factors shape a landscape where technical innovation must be matched by robust commercialization and support models to achieve sustained clinical integration.

Actionable strategic recommendations for technology developers and health systems to align product roadmaps, service models, and procurement approaches for sustainable intraoperative imaging adoption

Industry leaders should prioritize a balanced strategy that aligns technology development with pragmatic deployment and support structures. First, accelerate investment in software platforms that enable interoperability, cloud-enabled analytics, and modular upgrades so that hardware investments retain value over multiple clinical cycles. Building a clear API strategy and embracing standards-based interoperability will facilitate integration into electronic health records and surgical navigation suites, reducing friction for clinical teams. Second, expand regional manufacturing and distribution capabilities to mitigate trade-policy risks and shorten lead times; this improves resilience against tariff-driven cost shocks and enhances after-sales responsiveness.

Third, invest in comprehensive service and clinical training programs that emphasize procedure-specific workflows, competency assessments, and outcome tracking; these efforts strengthen clinician confidence and lower barriers to adoption. Fourth, pursue targeted clinical partnerships to generate real-world evidence that demonstrates procedural benefits, safety, and workflow efficiencies-evidence that procurement committees and health technology assessment bodies increasingly require. Fifth, explore flexible commercial models, including subscription and outcome-linked pricing, to align incentives across providers and payers. Finally, maintain a disciplined M&A and partnership strategy focused on acquiring complementary software capabilities and regional support assets rather than duplicative hardware portfolios. Collectively, these actions will position organizations to capture the benefits of intraoperative imaging adoption while managing operational and regulatory complexity.

A rigorous mixed-methods research approach integrating clinician interviews, supply chain mapping, regulatory review, and evidence triangulation to validate intraoperative imaging insights

The research methodology underpinning this executive summary combined qualitative primary research with structured secondary analysis to ensure findings reflect both practitioner experience and contextual industry signals. Primary research included in-depth interviews with surgeons, biomedical engineering leaders, procurement officials, and clinical operations managers to capture first-hand perspectives on technology performance, training needs, and procurement priorities. These interviews were complemented by expert roundtables that explored practical challenges around hybrid operating room design, modality selection, and post-market support strategies.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, technical standards, and vendor product documentation to establish an objective baseline for modality capabilities and clinical use cases. Supply chain mapping exercises identified component dependencies and regional manufacturing footprints, while case study analyses illustrated successful implementation patterns and avoided pitfalls. Findings were triangulated across data sources to validate themes and to differentiate one-off observations from systemic trends. Finally, analysis emphasized transparency in assumptions, rigorous documentation of interview protocols, and an audit trail of sources to support reproducibility and executive-level confidence in the report's conclusions.

Concluding synthesis on how integrated technology, evidence-based deployment, and resilient commercialization strategies will determine success in intraoperative imaging adoption

Intraoperative imaging is maturing from a collection of disparate tools into cohesive, clinically integrated systems that materially influence surgical precision and patient outcomes. The convergence of multimodal hardware, sophisticated software, and enhanced service models is creating opportunities for hospitals and ambulatory centers to reimagine procedural pathways and improve value delivery. At the same time, external forces-such as trade policy shifts, regional regulatory variance, and evolving reimbursement priorities-are reshaping procurement strategies and vendor selection criteria. Stakeholders who align technical innovation with durable service infrastructure and robust clinical evidence will be best positioned to realize the full benefits of intraoperative imaging investments.

Looking ahead, the emphasis will continue to shift toward platforms that enable iterative improvement through software updates, seamless interoperability with clinical systems, and strong aftermarket support. Organizations that proactively address supply chain risks and invest in clinician training will reduce friction in adoption and accelerate realization of clinical and operational benefits. Ultimately, the most successful entrants will be those that pair technological excellence with pragmatic, regionally informed commercialization strategies that answer the real-world needs of surgical teams and health system administrators.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative Imaging Market, by Modality

  • 8.1. Computed Tomography
  • 8.2. Endoscopy
    • 8.2.1. Flexible
    • 8.2.2. Rigid
  • 8.3. Fluoroscopy
  • 8.4. Magnetic Resonance Imaging
  • 8.5. Ultrasound

9. Intraoperative Imaging Market, by Component

  • 9.1. Equipment
  • 9.2. Service
    • 9.2.1. Maintenance
    • 9.2.2. Training
  • 9.3. Software

10. Intraoperative Imaging Market, by Application

  • 10.1. Cardiovascular
  • 10.2. General Surgery
  • 10.3. Neurosurgery
  • 10.4. Orthopedic
  • 10.5. Urology

11. Intraoperative Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Intraoperative Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intraoperative Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intraoperative Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Intraoperative Imaging Market

16. China Intraoperative Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Brainlab AG
  • 17.6. Canon Medical Systems Corporation
  • 17.7. Fujifilm Holdings Corporation
  • 17.8. GE Healthcare Holdings, Inc.
  • 17.9. Hologic, Inc.
  • 17.10. Karl Storz SE & Co. KG
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Medtronic plc
  • 17.13. Mindray Medical International Limited
  • 17.14. Olympus Corporation
  • 17.15. PerkinElmer, Inc.
  • 17.16. Philips Healthcare
  • 17.17. Shimadzu Corporation
  • 17.18. Siemens Healthineers AG
  • 17.19. Stryker Corporation
  • 17.20. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 162. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)